Emerald Mutual Fund Advisers Trust Alkermes Plc. Transaction History

Emerald Mutual Fund Advisers Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$25.31 - $29.02 $4.7 Million - $5.39 Million	185,807 Added 48.58%	568,314 $16 Million
Q4 2022 Feb 03, 2023	BUY	$21.94 - $26.24 $3.87 Million - $4.63 Million	176,327 Added 85.52%	382,507 $9.99 Million
Q3 2022 Oct 25, 2022	SELL	$22.0 - $31.87 $15.9 Million - $23.1 Million	-723,274 Reduced 77.82%	206,180 $4.6 Million
Q2 2022 Jul 29, 2022	BUY	$26.4 - $30.54 $24.5 Million - $28.4 Million	929,454 New	929,454 $27.7 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.